The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation information

Oral Presentation

(E) Biopharmaceutics

[29V08-am] がん②

Mon. Mar 29, 2021 10:24 AM - 12:00 PM [Room V08] Oral Presentation 8 (Online)

座長:佐藤 聡(東京理大薬)、小幡 徹(愛知学院大薬)

11:36 AM - 11:48 AM

[29V08-am14S] High SLC20A1 Expression is Associated with Poor Prognoses in Claudin-low and Basal-like Breast Cancers

○Chotaro Onaga1, Shoma Tamori1, Hitomi Motomura1, Ayaka Ozaki1, Chika Matsuda1, Izumi Matsuoka1, Takuma Fujita1, Yuka Nozaki1,2, Yasushi Hara3, Yohei Kawano1, Yohsuke Harada1, Tsugumichi Sato1, Yasunari Mano1, Keiko Sato4, Kazunori Akimoto1 (1. Pharm., Tokyo Univ. Sci., 2. National Cancer Center, 3. Grad. Sch. Bio. Sci., Tokyo Univ. Sci., 4. Sci. and Tech., Tokyo Univ. Sci.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password